Michael Low

Michael Low is an Adjunct Clinical Associate Professor in the Faculty of Medicine at Monash University and a practicing haematologist at Monash Health. He serves as Director of Physician Education at Casey Hospital and previously held the role of Director of Clinical Training at Monash Doctors Education (MDE). His clinical and academic work bridges patient care, pathology, and medical education.

His research is centered on myeloma and iron deficiency anaemia, with a focus on clinical trials and patient support. He has been the Myeloma Lead at Monash Health since 2017 and collaborates with organizations such as Myeloma Australia. His research contributions span clinical hematology, with a particular emphasis on multiple myeloma therapy and diagnostics.

Recent publications highlight his work in acute myeloid leukemia, multiple myeloma genetics, and rare hematologic co-malignancies. His studies often involve real-world data, diagnostic accuracy, and treatment efficacy, frequently in collaboration with the Australian Leukaemia and Lymphoma Group (ALLG). The trend in his research shows a strong commitment to improving clinical outcomes through evidence-based hematology.

Michael Low is actively leading multiple clinical trials as a Primary Chief Investigator, including Phase 3 studies in relapsed/refractory multiple myeloma and post-transplant maintenance therapies. His role in national working groups and registry-based research underscores his influence in the Australian hematology community.